NDAC AND EE TABLETS AND FERROUS FUMARATE TABLETS

NDAC AND EE TABLETS AND FERROUS FUMARATE TABLETS was reported 0 times

NDAC AND EE TABLETS AND FERROUS FUMARATE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOLESTEROSIS 1 0.0039
1 RENAL APLASIA 2 0.0028
2 COSTOCHONDRITIS 1 0.0006
3 BILIARY DYSKINESIA 1 0.0006
4 INJECTION SITE PAPULE 1 0.0002
5 INTERCEPTED MEDICATION ERROR 1 0.0002
6 PRODUCT COLOUR ISSUE 1 0.0002
7 ANKYLOSING SPONDYLITIS 2 0.0002
8 CHOLECYSTITIS CHRONIC 1 0.0001
9 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
10 MENSTRUAL DISORDER 1 0.0001
11 PRODUCT PACKAGING ISSUE 1 0.0001
12 INJECTION SITE NODULE 1 0.0001
13 CHOLECYSTITIS 1 0.0001
14 IMPAIRED GASTRIC EMPTYING 1 0.0001
15 IMPAIRED QUALITY OF LIFE 1 0.0001
16 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
17 PANIC ATTACK 2 0.0001
18 CHOLESTASIS 1 0.0001
19 ORAL HERPES 1 0.0001
20 INJECTION SITE WARMTH 1 0.0000
21 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
22 INJECTION SITE URTICARIA 1 0.0000
23 FREQUENT BOWEL MOVEMENTS 1 0.0000
24 SKIN LESION 1 0.0000
25 RESPIRATORY DISTRESS 1 0.0000
26 INJECTION SITE RASH 1 0.0000
27 EMOTIONAL DISORDER 1 0.0000
28 PRODUCT DOSE OMISSION 2 0.0000
29 INJECTION SITE PRURITUS 2 0.0000
30 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
31 LYMPHADENOPATHY 1 0.0000
32 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
33 PSORIATIC ARTHROPATHY 1 0.0000
34 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
35 COLITIS ULCERATIVE 1 0.0000
36 LUNG DISORDER 1 0.0000
37 DYSPEPSIA 2 0.0000
38 FLUSHING 2 0.0000
39 THERAPY CESSATION 1 0.0000
40 ABDOMINAL DISTENSION 2 0.0000
41 ECZEMA 1 0.0000
42 DERMATITIS ATOPIC 1 0.0000
43 PANCREATITIS 1 0.0000
44 HAEMATOCHEZIA 1 0.0000
45 EYE PAIN 1 0.0000
46 LETHARGY 1 0.0000
47 MUSCLE SPASMS 3 0.0000
48 INJECTION SITE ERYTHEMA 2 0.0000
49 RHINORRHOEA 1 0.0000
50 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
51 INJECTION SITE REACTION 1 0.0000
52 BURNING SENSATION 1 0.0000
53 EPISTAXIS 1 0.0000
54 INJECTION SITE SWELLING 1 0.0000
55 INJECTION SITE PAIN 4 0.0000
56 INJECTION SITE BRUISING 1 0.0000
57 INJECTION SITE HAEMORRHAGE 1 0.0000
58 INFLUENZA LIKE ILLNESS 1 0.0000
59 CARDIAC ARREST 1 0.0000
60 GASTROINTESTINAL DISORDER 1 0.0000
61 CHEST PAIN 2 0.0000
62 ANXIETY 3 0.0000
63 SINUSITIS 1 0.0000
64 RHEUMATOID ARTHRITIS 1 0.0000
65 MUSCULAR WEAKNESS 1 0.0000
66 DEPRESSION 2 0.0000
67 SEIZURE 1 0.0000
68 PALPITATIONS 1 0.0000
69 CHILLS 1 0.0000
70 PRODUCT QUALITY ISSUE 1 0.0000
71 COUGH 2 0.0000
72 PRODUCT DOSE OMISSION ISSUE 2 0.0000
73 CONDITION AGGRAVATED 2 0.0000
74 HEADACHE 4 0.0000
75 PARAESTHESIA 1 0.0000
76 TOXICITY TO VARIOUS AGENTS 1 0.0000
77 MYALGIA 1 0.0000
78 PYREXIA 2 0.0000
79 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
80 NASOPHARYNGITIS 1 0.0000
81 PRURITUS 2 0.0000
82 ERYTHEMA 1 0.0000
83 ABDOMINAL PAIN UPPER 1 0.0000
84 ARTHRALGIA 2 0.0000
85 HYPERTENSION 1 0.0000
86 DIARRHOEA 3 0.0000
87 CONSTIPATION 1 0.0000
88 DECREASED APPETITE 1 0.0000
89 ABDOMINAL PAIN 1 0.0000
90 WEIGHT DECREASED 1 0.0000
91 DYSPNOEA 2 0.0000
92 PAIN IN EXTREMITY 1 0.0000
93 PAIN 2 0.0000
94 PNEUMONIA 1 0.0000
95 FALL 1 0.0000
96 FATIGUE 2 0.0000
97 RASH 1 0.0000
98 MALAISE 1 0.0000
99 VOMITING 1 0.0000
100 DRUG INEFFECTIVE 2 0.0000
101 NAUSEA 1 0.0000
102 OFF LABEL USE 1 0.0000